Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 22 de sept. de 2008 · Using the Novalis Tx platform from Varian Medical Systems (NYSE: VAR) and BrainLAB, doctors are performing image-guided radiosurgery to treat tumors of the brain, spine, lung, and liver, without a single incision in the patient.

  2. With the Novalis Tx radiosurgery platform, UCLA offers state-of-the-art, non-invasive treatment for a wide range of malignancies and other potentially debilitating conditions, without harming nearby healthy tissue and without involving traditional surgery.

  3. The ultra-precise Novalis Tx radiosurgical instrument will use a variety of standard and configurable options including Varian's On-board Imager® device, the BrainLAB ExacTrac® X-Ray 6D room mounted X-Ray imaging system, BrainLAB iPLAN® treatment planning software as well as Varian's Eclipse™ treatment planning and ARIA™ information ...

  4. Brainlab Novalis SRS Registry* is a service that supports all clinical specialties involved in radiosurgical diagnoses and treatments with tools for reporting, intelligently structuring and visualizing clinical data from different sources to advance patient-specific treatment decisions.

    • novalis tx software1
    • novalis tx software2
    • novalis tx software3
    • novalis tx software4
    • novalis tx software5
  5. 7 de dic. de 2022 · Novalis Tx is a modality integrated with Varian and Brainlab technologies, and provides the ability of 2-D and 3-D multi-imaging (kV, MV) for treatment. Treatment delivery can either use intensity-modulated radiation therapy or conformal radiation therapy to deliver static beam or arc therapy.

  6. The Novalis Tx™ platform from Varian Medical Systems and BrainLAB enables doctors to perform image-guided radiosurgery on tumors of the lung, as well as of the brain, spine, liver, and prostate, without making a single incision.

  7. 10 de may. de 2012 · We have demonstrated the Novalis Tx to be a robust system, with the image guidance and MLC requirements to treat a wide variety of sites, in addition to achieving the requirements for highly accurate delivery of SRS and SBRT‐based treatments.